These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9831363)

  • 21. Expression and mutational analysis of Nm23-H1 in liver metastases of colorectal cancer.
    Heide I; Thiede C; Poppe K; de Kant E; Huhn D; Rochlitz C
    Br J Cancer; 1994 Dec; 70(6):1267-71. PubMed ID: 7981087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of nm23-H1 and nm23-H2 proteins in prostate carcinoma.
    Konishi N; Nakaoka S; Tsuzuki T; Matsumoto K; Kitahori Y; Hiasa Y; Urano T; Shiku H
    Jpn J Cancer Res; 1993 Oct; 84(10):1050-4. PubMed ID: 7693635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NM23 gene expression in human breast carcinomas: loss of correlation with cell proliferation in the advanced phase of tumor progression.
    Caligo MA; Cipollini G; Berti A; Viacava P; Collecchi P; Bevilacqua G
    Int J Cancer; 1997 Feb; 74(1):102-11. PubMed ID: 9036878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased activity of nm23-H1 gene in squamous cell carcinoma of the head and neck is associated with advanced disease and poor prognosis.
    Pavelić K; Kapitanović S; Radosević S; Bura M; Seiwerth S; Pavelić LJ; Unusić J; Spaventi R
    J Mol Med (Berl); 2000; 78(2):111-8. PubMed ID: 10794547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of proliferating cell nucleus antigen and nm23 protein and their relation with metastasis in hepatocellular carcinoma].
    Luo HY; Wang HC; Feng DY
    Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):17-9. PubMed ID: 12934386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of nm23 in gastric carcinoma: association with tumor progression and poor prognosis.
    Müller W; Schneiders A; Hommel G; Gabbert HE
    Cancer; 1998 Dec; 83(12):2481-7. PubMed ID: 9874452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomerase activity and Nm23-H2 protein expression in hepatocellular carcinoma.
    Iizuka N; Mori N; Tamesa T; Tangoku A; Oka M
    Anticancer Res; 2003; 23(1A):43-7. PubMed ID: 12680194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.
    Tian J; Tang ZY; Ye SL; Liu YK; Lin ZY; Chen J; Xue Q
    Br J Cancer; 1999 Nov; 81(5):814-21. PubMed ID: 10555751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer.
    Brenner AS; Thebo JS; Senagore AJ; Duepree HJ; Gramlich T; Ormsby A; Lavery IC; Fazio VW
    Am Surg; 2003 Mar; 69(3):203-8; discussion 208. PubMed ID: 12678475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P53 is a regulator of the metastasis suppressor gene Nm23-H1.
    Chen SL; Wu YS; Shieh HY; Yen CC; Shen JJ; Lin KH
    Mol Carcinog; 2003 Apr; 36(4):204-14. PubMed ID: 12669312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma.
    Tannapfel A; Köckerling F; Katalinic A; Wittekind C
    Dis Colon Rectum; 1995 Jun; 38(6):651-4. PubMed ID: 7774480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of nm23-H1 in transitional cell carcinoma of the upper urinary tract.
    Cheng HL; Tong YC; Tzai TS; Weng CL; Ho CL; Yang WH; Lin JS; Chow NH
    Oncol Rep; 2001; 8(1):193-6. PubMed ID: 11115597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.
    Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE
    Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.
    Goncharuk VN; del-Rosario A; Kren L; Anwar S; Sheehan CE; Carlson JA; Ross JS
    Ann Diagn Pathol; 2004 Feb; 8(1):6-16. PubMed ID: 15129904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
    Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of nm23-H1 in colorectal cancer: no association with metastases, histological stage, or survival.
    Tabuchi Y; Nakamura T; Kuniyasu T; Ohno M; Nakae S
    Surg Today; 1999; 29(2):116-20. PubMed ID: 10030735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of nm23-H1 in the progression of transitional cell bladder cancer.
    Chow NH; Liu HS; Chan SH
    Clin Cancer Res; 2000 Sep; 6(9):3595-9. PubMed ID: 10999750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of all-trans retinoic acid and epidermal growth factor on the expression of nm23-H1 in human hepatocarcinoma cells.
    Liu F; Qi HL; Chen HL
    J Cancer Res Clin Oncol; 2000 Feb; 126(2):85-90. PubMed ID: 10664247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic implication of nm23-H1 expression in colorectal carcinomas.
    Dursun A; Akyürek N; Günel N; Yamaç D
    Pathology; 2002 Oct; 34(5):427-32. PubMed ID: 12408341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prediction of lymph node metastases in colorectal cancer by expression of the nucleoside diphosphate kinase/nm23-H1 and histopathological variables.
    Tannapfel A; Katalinic A; Köckerling F; Wittekind C
    Am J Gastroenterol; 1997 Jul; 92(7):1182-6. PubMed ID: 9219795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.